Mersana Therapeutics, Inc.·4

Feb 6, 4:25 PM ET

Kaufman Michael J. 4

4 · Mersana Therapeutics, Inc. · Filed Feb 6, 2018

Insider Transaction Report

Form 4
Period: 2018-02-02
Kaufman Michael J.
Sr VP Chmistry, Man & Control
Transactions
  • Award

    Stock Option (right to buy)

    2018-02-02+50,05750,057 total
    Exercise: $14.23Exp: 2028-02-01Common Stock (50,057 underlying)
Footnotes (1)
  • [F1]The options vest in equal quarterly installments over the first four years after the vesting commencement date, February 2, 2018.

Documents

1 file
  • 4
    a4.xmlPrimary

    4